Compare AMETEK, Inc. (AME) vs Cardinal Health Inc (CAH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AMETEK, Inc. vs Cardinal Health Inc — how do they compare? AMETEK, Inc. trades at $233.43 (market cap $53.63B), while Cardinal Health Inc trades at $235.73 (market cap $55.23B). The key difference: AMETEK, Inc. and Cardinal Health Inc are close in size by market cap, and Cardinal Health Inc pays the higher dividend (0.87%). Which is the better fit depends on your goals.
| AME | CAH | |
|---|---|---|
Market Cap | $53.63B | $55.23B |
Sector | Industrials | Health |
52-Week High | $241.94 | $239.71 |
52-Week Low | $176.44 | $146.04 |
Enterprise Value | $55.33B | $60.20B |
Dividend Yield | 0.58% | 0.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AME trades at $233.98, up 0.42% today, with a neutral technical signal and strong fundamentals including three consecutive quarterly EPS beats. The company maintains robust profitability with a 20.11% net margin and recently completed the acquisition of First Aviation Services, expanding its aerospace and defense footprint. Cash flow remains positive with $83.95M net inflow in 2025.
Outlook is positive with a $260 consensus price target representing 11% upside, supported by 68.97% analyst buy ratings. Risks include elevated P/E of 35.34 and integration challenges from recent acquisitions. The stock offers growth exposure to industrial technology and aerospace sectors with stable dividend payments.
Cardinal Health (CAH) trades at $235.80, up 0.87% with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with 37.08% ROE and positive revenue growth trends from $222.58B in 2025 to projected $250.7B in 2026. Recent removal from Russell indices has not dampened analyst optimism, with 54.55% maintaining buy ratings and a $248 consensus price target representing 5% upside potential.
The outlook remains positive given CAH's defensive healthcare distribution business and specialty pharma expansion. Key risks include negative shareholder equity of -$3.21B and elevated debt levels with 16.09% debt-to-asset ratio. Earnings momentum from three consecutive quarterly beats supports the bullish case, though investors should monitor the upcoming Q2 2026 results against $2.41 EPS expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AMETEK, Inc.
Ametek is a diversified industrial conglomerate with over $6 billion in sales. The firm operates through an electronic instruments group and an electromechanical group. EIG designs and manufactures differentiated and advanced instruments for the process, aerospace, power, and industrial end markets. EMG is a focused, niche supplier of highly engineered automation solutions, thermal management systems, specialty metals, and electrical interconnects, among other products. About half of the firm's sales are made in the United States. The firm's asset-light strategy in place for nearly two decades emphasizes growth through acquisitions, new product development through research and development, driving operational efficiencies, and global and market expansion.
Read more on AME →About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →
